Literature DB >> 19362356

Toll-like receptor 3 enhances late-phase reaction of experimental allergic conjunctivitis.

Mayumi Ueta, Satoshi Uematsu, Shizuo Akira, Shigeru Kinoshita.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19362356     DOI： 10.1016/j.jaci.2009.03.008

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  4 in total

1.  Toll-like receptor 3 increases allergic and irritant contact dermatitis.

Authors:  Naomi Nakamura; Risa Tamagawa-Mineoka; Mayumi Ueta; Shigeru Kinoshita; Norito Katoh
Journal:  J Invest Dermatol       Date:  2014-09-17       Impact factor: 8.551

2.  TSLP and downstream molecules in experimental mouse allergic conjunctivitis.

Authors:  Xiaofen Zheng; Ping Ma; Cintia S de Paiva; Matthew A Cunningham; Cindy S Hwang; Stephen C Pflugfelder; De-Quan Li
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-27       Impact factor: 4.799

3.  Difference in the plasma level of miR-628-3p in atopic dermatitis patients with/without atopic keratoconjunctivitis.

Authors:  Mayumi Ueta; Hiromi Nishigaki; Seitaro Komai; Chie Sotozono; Shigeru Kinoshita
Journal:  Immun Inflamm Dis       Date:  2021-09-21

Review 4.  Susceptibility Genes and HLA for Cold Medicine-Related SJS/TEN with SOC.

Authors:  Mayumi Ueta
Journal:  Front Genet       Date:  2022-07-11       Impact factor: 4.772
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.